Cargando…
Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials
BACKGROUND: Acinetobacter infections, especially multidrug-resistant (MDR) Acinetobacter infections, are a global health problem. This study aimed to describe clinical outcomes in patients with confirmed Acinetobacter spp. isolates who were treated with tigecycline in randomized clinical trials. MAT...
Autores principales: | Tucker, Hal, Wible, Michele, Gandhi, Ashesh, Quintana, Alvaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679678/ https://www.ncbi.nlm.nih.gov/pubmed/29138583 http://dx.doi.org/10.2147/IDR.S143306 |
Ejemplares similares
-
Pancreatitis in tigecycline Phase 3 and 4 clinical studies
por: McGovern, Paul C., et al.
Publicado: (2014) -
Combination Treatment with Intravenous Tigecycline and Intraventricular and Intravenous Colistin in Postoperative Ventriculitis Caused by Multidrug-resistant Acinetobacter baumannii
por: Mizrahi, Cezar J, et al.
Publicado: (2019) -
The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020) -
Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023) -
A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia
por: Reed, Gregory A., et al.
Publicado: (2016)